{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:04:14Z","timestamp":1761177854402,"version":"build-2065373602"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,22]]},"DOI":"10.7759\/cureus.95142","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T11:37:37Z","timestamp":1761133057000},"source":"Crossref","is-referenced-by-count":0,"title":["Intravenous Albumin for Oedema in Children With Nephrotic Syndrome: A Systematic Review and Mapping of the Evidence Landscape"],"prefix":"10.7759","author":[{"given":"Sohaib B","family":"Nawaz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Ashfaq","family":"Zafar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14184-0","article-title":"Nephrotic syndrome in childhood","volume":"362","author":"Eddy AA","year":"2003","unstructured":"Eddy AA, Symons JM. Nephrotic syndrome in childhood. Lancet. 2003, 362:629-39. 10.1016\/S0140-6736(03)14184-0","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3329\/bjch.v38i2.21139","article-title":"Albumin and furosemide versus mannitol and furosemide in the treatment of diuretic resistant oedema in childhood nephrotic syndrome","volume":"38","author":"Huque SS","year":"2014","unstructured":"Huque SS, Rahman MH, Uddin GM, Jahan S, Begum A, Roy RR, Hossain MM. Albumin and furosemide versus mannitol and furosemide in the treatment of diuretic resistant oedema in childhood nephrotic syndrome. Bangladesh J Child Health. 2014, 38:74-8. 10.3329\/bjch.v38i2.21139","journal-title":"Bangladesh J Child Health"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-021-05358-4","article-title":"Furosemide and albumin for the treatment of nephrotic edema: a systematic review","volume":"37","author":"Hedin E","year":"2022","unstructured":"Hedin E, Bijeli\u0107 V, Barrowman N, Geier P. Furosemide and albumin for the treatment of nephrotic edema: a systematic review. Pediatr Nephrol. 2022, 37:1747-57. 10.1007\/s00467-021-05358-4","journal-title":"Pediatr Nephrol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1159\/000183392","article-title":"Sodium retention in nephrotic syndrome is due to an intrarenal defect: evidence from steroid-induced remission","volume":"39","author":"Brown EA","year":"1985","unstructured":"Brown EA, Markandu N, Sagnella GA, Jones BE, MacGregor GA. Sodium retention in nephrotic syndrome is due to an intrarenal defect: evidence from steroid-induced remission. Nephron. 1985, 39:290-5. 10.1159\/000183392","journal-title":"Nephron"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009692.pub2","article-title":"Human albumin infusion for treating oedema in people with nephrotic syndrome","volume":"7","author":"Ho JJ","year":"2019","unstructured":"Ho JJ, Adnan AS, Kueh YC, Ambak NJ, Van Rostenberghe H, Jummaat F. Human albumin infusion for treating oedema in people with nephrotic syndrome. Cochrane Database Syst Rev. 2019, 7:CD009692. 10.1002\/14651858.CD009692.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1172\/jci110756","article-title":"Role for intrarenal mechanisms in the impaired salt excretion of experimental nephrotic syndrome","volume":"71","author":"Ichikawa I","year":"1983","unstructured":"Ichikawa I, Rennke HG, Hoyer JR, et al.. Role for intrarenal mechanisms in the impaired salt excretion of experimental nephrotic syndrome. J Clin Invest. 1983, 71:91-103. 10.1172\/jci110756","journal-title":"J Clin Invest"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1C320","article-title":"Combined furosemide and human albumin treatment for diuretic-resistant edema","volume":"37","author":"Elwell RJ","year":"2003","unstructured":"Elwell RJ, Spencer AP, Eisele G. Combined furosemide and human albumin treatment for diuretic-resistant edema. Ann Pharmacother. 2003, 37:695-700. 10.1345\/aph.1C320","journal-title":"Ann Pharmacother"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1999.00298.x","article-title":"Coadministration of albumin and furosemide in patients with the nephrotic syndrome","volume":"55","author":"Fliser D","year":"1999","unstructured":"Fliser D, Zurbr\u00fcggen I, Mutschler E, Bischoff I, Nussberger J, Franek E, Ritz E. Coadministration of albumin and furosemide in patients with the nephrotic syndrome. Kidney Int. 1999, 55:629-34. 10.1046\/j.1523-1755.1999.00298.x","journal-title":"Kidney Int"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/60.13.1330","article-title":"Evaluation of the appropriate use of albumin in adult and pediatric patients","volume":"60","author":"Tanzi M","year":"2003","unstructured":"Tanzi M, Gardner M, Megellas M, Lucio S, Restino M. Evaluation of the appropriate use of albumin in adult and pediatric patients. Am J Health Syst Pharm. 2003, 60:1330-5. 10.1093\/ajhp\/60.13.1330","journal-title":"Am J Health Syst Pharm"},{"key":"ref10","article-title":"Co-administration of albumin-furosemide in patients with the nephrotic syndrome","volume":"22","author":"Ghafari A","year":"2011","unstructured":"Ghafari A, Mehdizadeh A, Alavi-Darazam I, Rahimi E, Kargar C, Sepehrvand N. Co-administration of albumin-furosemide in patients with the nephrotic syndrome. Saudi J Kidney Dis Transpl. 2011, 22:471-5.","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-008-1062-0","article-title":"Randomized cross-over trial comparing albumin and frusemide infusions in nephrotic syndrome","volume":"24","author":"Dharmaraj R","year":"2009","unstructured":"Dharmaraj R, Hari P, Bagga A. Randomized cross-over trial comparing albumin and frusemide infusions in nephrotic syndrome. Pediatr Nephrol. 2009, 24:775-82. 10.1007\/s00467-008-1062-0","journal-title":"Pediatr Nephrol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aeg233","article-title":"Safety of human albumin--serious adverse events reported worldwide in 1998-2000","volume":"91","author":"Vincent JL","year":"2003","unstructured":"Vincent JL, Wilkes MM, Navickis RJ. Safety of human albumin--serious adverse events reported worldwide in 1998-2000. Br J Anaesth. 2003, 91:625-30. 10.1093\/bja\/aeg233","journal-title":"Br J Anaesth"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1542\/peds.91.6.1142","article-title":"Efficacy of albumin and diuretic therapy in children with nephrotic syndrome","volume":"91","author":"Haws RM","year":"1993","unstructured":"Haws RM, Baum M. Efficacy of albumin and diuretic therapy in children with nephrotic syndrome. Pediatrics. 1993, 91:1142-6. 10.1542\/peds.91.6.1142","journal-title":"Pediatrics"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2013.10.004","article-title":"Co-administration of furosemide with albumin for overcoming diuretic resistance in patients with hypoalbuminemia: a meta-analysis","volume":"29","author":"Kitsios GD","year":"2014","unstructured":"Kitsios GD, Mascari P, Ettunsi R, Gray AW. Co-administration of furosemide with albumin for overcoming diuretic resistance in patients with hypoalbuminemia: a meta-analysis. J Crit Care. 2014, 29:253-9. 10.1016\/j.jcrc.2013.10.004","journal-title":"J Crit Care"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/cl2.1230","article-title":"PRISMA2020: an R package and shiny app for producing Prisma 2020-compliant flow diagrams, with interactivity for optimised digital transparency and open synthesis","volume":"18","author":"Haddaway NR","year":"2022","unstructured":"Haddaway NR, Page MJ, Pritchard CC, McGuinness LA. PRISMA2020: an R package and shiny app for producing Prisma 2020-compliant flow diagrams, with interactivity for optimised digital transparency and open synthesis. Campbell Syst Rev. 2022, 18:e1230. 10.1002\/cl2.1230","journal-title":"Campbell Syst Rev"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.32553\/ijmbs.v5i1.1677","article-title":"Albumin versus fresh frozen plasma in managing diuretic resistant edema in children with idiopathic nephrotic syndrome","volume":"5","author":"Singh V","year":"2021","unstructured":"Singh V, Berwal PK, Saini TC, Mishra N. Albumin versus fresh frozen plasma in managing diuretic resistant edema in children with idiopathic nephrotic syndrome. Int J Med Biomed Stud. 2021, 5:232-4. 10.32553\/ijmbs.v5i1.1677","journal-title":"Int J Med Biomed Stud"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s004670100576","article-title":"Does albumin and furosemide therapy affect plasma volume in nephrotic children?","volume":"16","author":"Bircan Z","year":"2001","unstructured":"Bircan Z, Kervancio\u011flu M, Katar S, Vitrinel A. Does albumin and furosemide therapy affect plasma volume in nephrotic children?. Pediatr Nephrol. 2001, 16:497-9. 10.1007\/s004670100576","journal-title":"Pediatr Nephrol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3126\/jnps.v40i3.29110","article-title":"A crossover comparative study to assess efficacy of 5% vs. 20% albumin in the treatment of anasarca in children with idiopathic nephrotic syndrome","volume":"40","author":"Garg AK","year":"2020","unstructured":"Garg AK, Kalra S, Kumar A, Kanitkar M. A crossover comparative study to assess efficacy of 5% vs. 20% albumin in the treatment of anasarca in children with idiopathic nephrotic syndrome. J Nepal Paedtr Soc. 2020, 40:157-63. 10.3126\/jnps.v40i3.29110","journal-title":"J Nepal Paedtr Soc"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.310.6973.162","article-title":"Diuretic effect of frusemide in patients with nephrotic syndrome: is it potentiated by intravenous albumin?","volume":"310","author":"Akcicek F","year":"1995","unstructured":"Akcicek F, Yalniz T, Basci A, Ok E, Mees EJ. Diuretic effect of frusemide in patients with nephrotic syndrome: is it potentiated by intravenous albumin?. BMJ. 1995, 310:162-3. 10.1136\/bmj.310.6973.162","journal-title":"BMJ"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2001.16.4.448","article-title":"Does albumin preinfusion potentiate diuretic action of furosemide in patients with nephrotic syndrome?","volume":"16","author":"Na KY","year":"2001","unstructured":"Na KY, Han JS, Kim YS, et al.. Does albumin preinfusion potentiate diuretic action of furosemide in patients with nephrotic syndrome?. J Korean Med Sci. 2001, 16:448-54. 10.3346\/jkms.2001.16.4.448","journal-title":"J Korean Med Sci"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-008-9344-9","article-title":"Is edema in minimal change disease of childhood really hypovolemic?","volume":"40","author":"Tabel Y","year":"2008","unstructured":"Tabel Y, Mungan I, Karakurt C, Kocak G, Gungor S. Is edema in minimal change disease of childhood really hypovolemic?. Int Urol Nephrol. 2008, 40:757-61. 10.1007\/s11255-008-9344-9","journal-title":"Int Urol Nephrol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-009-1221-y","article-title":"Use of recombinant human serum albumin in pediatric patients with nephrotic syndrome","volume":"24","author":"Tsuruga K","year":"2009","unstructured":"Tsuruga K, Oki E, Yashiro T, Ito E, Tanaka H. Use of recombinant human serum albumin in pediatric patients with nephrotic syndrome. Pediatr Nephrol. 2009, 24:2275-6. 10.1007\/s00467-009-1221-y","journal-title":"Pediatr Nephrol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-014-2903-7","article-title":"Best practice guidelines for idiopathic nephrotic syndrome: recommendations versus reality","volume":"30","author":"Pasini A","year":"2015","unstructured":"Pasini A, Aceto G, Ammenti A, et al.. Best practice guidelines for idiopathic nephrotic syndrome: recommendations versus reality. Pediatr Nephrol. 2015, 30:91-101. 10.1007\/s00467-014-2903-7","journal-title":"Pediatr Nephrol"},{"key":"ref24","article-title":"Comparison of manitol and albumin treatment in diuretic resistant edema in children with nephrotic syndrome referred to Ali Asghar Children Hospital in 2002","volume":"11","author":"Otukesh H","year":"2004","unstructured":"Otukesh H, Hosseini Shams Abadi R. Comparison of manitol and albumin treatment in diuretic resistant edema in children with nephrotic syndrome referred to Ali Asghar Children Hospital in 2002. Razi J Med Sci. 2004, 11:343-9.","journal-title":"Razi J Med Sci"},{"key":"ref25","article-title":"The effect of human albumin infusion on the clinical course of steroid sensitive nephrotic syndrome","volume":"4","author":"Lee SJ","year":"2000","unstructured":"Lee SJ, Jeong JA, Hwang SJ, Lee SJ. The effect of human albumin infusion on the clinical course of steroid sensitive nephrotic syndrome. J Korean Soc Pediatr Nephrol. 2000, 4:102-10.","journal-title":"J Korean Soc Pediatr Nephrol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3390\/cells4040622","article-title":"Albumin and furosemide combination for management of edema in nephrotic syndrome: a review of clinical studies","volume":"4","author":"Duffy M","year":"2015","unstructured":"Duffy M, Jain S, Harrell N, Kothari N, Reddi AS. Albumin and furosemide combination for management of edema in nephrotic syndrome: a review of clinical studies. Cells. 2015, 4:622-30. 10.3390\/cells4040622","journal-title":"Cells"},{"key":"ref27","article-title":"[The effect of albumin and furosemide administration in children with primary nephrotic syndrome (author's transl)]","volume":"10","author":"Rego Filho Ede A","year":"1977","unstructured":"Rego Filho Ede A, Casoni W. [The effect of albumin and furosemide administration in children with primary nephrotic syndrome (author's transl)]. Rev Bras Pesqui Med Biol. 1977, 10:299-304.","journal-title":"Rev Bras Pesqui Med Biol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/420244-intravenous-albumin-for-oedema-in-children-with-nephrotic-syndrome-a-systematic-review-and-mapping-of-the-evidence-landscape","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T11:37:38Z","timestamp":1761133058000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/420244-intravenous-albumin-for-oedema-in-children-with-nephrotic-syndrome-a-systematic-review-and-mapping-of-the-evidence-landscape"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.95142","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,22]]}}}